Pooled Analysis of Tanezumab Efficacy and Safety with Subgroup Analyses of Phase III Clinical Trials in Patients with Osteoarthritis Pain of the Knee or Hip [Corrigendum]
Tive L, Bello AE, Radin D, et al. J Pain Res. 2019;12:975 —995. The authors have advised there is an error in the middle panels of Figure 6 on page 985. Both panels read “Patients with severe OA” the panel on the right should read &am...
Main Authors: | Tive L, Bello AE, Radin D, Schnitzer TJ, Nguyen H, Brown MT, West CR |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-09-01
|
Series: | Journal of Pain Research |
Subjects: | |
Online Access: | https://www.dovepress.com/corrigendum-pooled-analysis-of-tanezumab-efficacy-and-safety-with-subg-peer-reviewed-article-JPR |
Similar Items
-
Pooled analysis of tanezumab efficacy and safety with subgroup analyses of phase III clinical trials in patients with osteoarthritis pain of the knee or hip
by: Tive L, et al.
Published: (2019-03-01) -
Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritis
by: Birbara C, et al.
Published: (2018-01-01) -
Clinical Outcomes of Tanezumab With Different Dosages for Patient With Osteoarthritis: Network Meta-Analysis
by: Rui Hu, et al.
Published: (2021-06-01) -
Use of tanezumab for chronic pain treatment
by: A. E. Karateev, et al.
Published: (2021-05-01) -
Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis
by: Mona K Patel, et al.
Published: (2018-01-01)